Contract facts
FederalNo full NAICS 325413 intel page yet. Browse NAICS intelligence
Cobas 6000 Chemical Analyzer, Reagents and Test Kits - Firm Fixed PRICE. 5 Year Ordering PERIOD. Contractor Shall Provi… is a federal award for Fa3020 82 Cons Lgc held by Roche Diagnostics Corp. Estimated value $137K ($111K obligated). Current period of performance ends Sep 30, 2024 (potential Sep 30, 2026). Place of performance: SHEPPARD AFB TX.
Cobas 6000 chemical analyzer, reagents and test kits - firm fixed price. 5 year ordering period. contractor shall provide cobas 6000 chemical analyzer, reagents and test kits as defined in the performance work statement and in accordance with the pri. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Sep 30, 2024 (751 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on FA302023F0294? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA302023F0294?
FA302023F0294 (Cobas 6000 chemical analyzer reagents and) is a Fa3020 82 Cons Lgc award with a potential value of $137K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is FA3020-23-F-0294?
FA3020-23-F-0294 is the dashed form of PIID FA302023F0294 (Cobas 6000 chemical analyzer reagents and), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded FA302023F0294?
Fa3020 82 Cons Lgc awarded FA302023F0294 to Roche Diagnostics Corp (potential $137K).
Who is the incumbent on FA302023F0294?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2024.
When does Roche Diagnostics Corp’s FA302023F0294 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on FA302023F0294? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.